Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke

NCT00235495 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT00235495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Lead sponsor
University of Miami
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2006
Completion date
February 28, 2013
Enrollment
841 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke